Epidemiology of pediatric uveitis and associated systemic diseases

Yoonkyeom Shin1, Ji-Man Kang1,2, Junwon Lee3

  • 1Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.

Insights

Early detection of childhood uveitis is crucial. In Korea, nearly one-third of pediatric uveitis cases are linked to systemic rheumatic diseases, primarily juvenile idiopathic arthritis (JIA).

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Pediatrics

Background:

  • Early detection of uveitis in children with systemic inflammatory diseases is vital for prognosis.
  • Diagnosis can be challenging due to examination difficulties and subtle early symptoms.
  • This study aimed to characterize childhood uveitis patterns and rheumatic disease associations.

Purpose of the Study:

  • To identify the epidemiological patterns of childhood uveitis.
  • To investigate the frequency and clinical features of rheumatic diseases in pediatric uveitis patients.
  • To explore potential risk factors for JIA-associated uveitis.

Main Methods:

  • Retrospective observational study of pediatric uveitis patients (≤18 years) from 2005-2018.
  • Data included demographics, uveitis characteristics, comorbidities, complications, and lab results.
  • Statistical analysis used Fisher's exact test and Mann-Whitney U test.

Main Results:

  • 155 children with uveitis were analyzed; median age at diagnosis was 13.0 years.
  • Idiopathic uveitis was most common (65.2%); 28.4% had systemic rheumatic diseases, predominantly juvenile idiopathic arthritis (JIA, 14.8%).
  • Human leukocyte antigen (HLA)-B27 and antinuclear antibody (ANA) positivity were higher in JIA-associated uveitis.

Conclusions:

  • Systemic rheumatic diseases, especially JIA, are associated with approximately one-third of pediatric uveitis cases in Korea.
  • HLA-B27 and ANA may indicate increased risk for JIA-associated uveitis.
  • Further research into early diagnostic markers for pediatric uveitis is warranted.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
61
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
110
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
82
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
109
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.1K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
246